Engineered immune cells take on Hard-to-Treat cancers
Disease control
Completed
This early-stage trial tests a treatment called Anti-CEA CAR-T, which uses a patient's own immune cells modified to recognize and attack cancer cells that carry a protein called CEA. The study enrolls about 110 adults with advanced colorectal, gastric, or other solid tumors that …
Phase: PHASE1 • Sponsor: Weijia Fang, MD • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC